What Is Chemotherapy for Lung Cancer?
Chemotherapy uses cytotoxic drugs to destroy cancer cells or stop them dividing. Because it circulates through the bloodstream, it can reach cancer cells that have spread beyond the primary tumour - making it especially useful in lung cancer, where microscopic spread is common. It is used across all stages of NSCLC and SCLC: before surgery, after surgery, with radiotherapy, and as primary treatment for advanced disease.
When Is Chemotherapy Used for Lung Cancer?
For Non-Small Cell Lung Cancer (NSCLC)
Chemotherapy is used at several points in the NSCLC pathway:
- Neoadjuvant (before surgery) - combined with immunotherapy to shrink the tumour
- Adjuvant (after surgery) - for Stage II-IIIA NSCLC; followed by osimertinib if EGFR-positive or immunotherapy if PD-L1 is high
- Concurrent chemoradiation - given with radical radiotherapy for unresectable Stage III, typically followed by durvalumab
- First-line metastatic - combined with immunotherapy for advanced NSCLC without actionable mutations
For Small Cell Lung Cancer (SCLC)
Chemotherapy is the cornerstone of SCLC treatment, as this cancer responds well to cytotoxic drugs and has usually spread at diagnosis:
- Limited-stage SCLC - cisplatin or carboplatin with etoposide concurrently with chest radiotherapy; prophylactic cranial irradiation may follow
- Extensive-stage SCLC - carboplatin or cisplatin with etoposide plus atezolizumab or durvalumab for eligible patients
- Relapsed SCLC - topotecan, lurbinectedin, or platinum-etoposide re-challenge depending on treatment-free interval
Which Chemotherapy Drugs Are Used?
NSCLC Drug Combinations
Most NSCLC regimens use cisplatin or carboplatin paired with a second drug:
- Carboplatin or cisplatin + pemetrexed (preferred for non-squamous/adenocarcinoma)
- Carboplatin or cisplatin + paclitaxel or docetaxel
- Carboplatin or cisplatin + gemcitabine (commonly used in squamous cell NSCLC)
- Carboplatin or cisplatin + vinorelbine
Pembrolizumab or atezolizumab may be added for eligible patients with advanced NSCLC. Cisplatin offers slightly stronger efficacy but greater toxicity; carboplatin is better tolerated and used in older patients or those with reduced kidney function.
SCLC Drug Combinations
- Cisplatin + etoposide (preferred for limited-stage)
- Carboplatin + etoposide (more commonly used in extensive-stage due to better tolerability)
- Carboplatin + etoposide + atezolizumab or durvalumab (first-line extensive-stage with immunotherapy)
How Is Chemotherapy Given?
Lung cancer chemotherapy is given intravenously - through a drip into a vein. Patients with difficult veins may have a PICC line or port fitted for comfort.
Treatment runs in cycles, typically three to four weeks long: you receive the drugs over one to a few days, then rest to allow healthy cells to recover. Most regimens involve four to six cycles. A typical cycle looks like this:
- Blood tests before each cycle - kidney function, liver enzymes, and blood counts
- Infusion - carboplatin takes one to two hours; cisplatin needs longer hydration
- Rest at home for two to three weeks
- Repeat until cycles are complete or response is reassessed
Treatment is given in a hospital day unit. An overnight stay is rarely needed.
Side Effects of Chemotherapy for Lung Cancer
Chemotherapy targets rapidly dividing cells, which includes cancer cells but also some healthy tissues such as the bone marrow, gut lining, and hair follicles. Side effects vary by drug combination.
Common Side Effects
- Fatigue - the most commonly reported; tends to worsen across cycles
- Nausea and vomiting - anti-nausea medicines prescribed proactively
- Hair loss - most common with paclitaxel and docetaxel
- Reduced appetite, mouth sores, and bowel changes
Side Effects Requiring Close Monitoring
- Neutropenia - low white blood cell count increases infection risk; G-CSF injections and pre-cycle blood tests help manage this
- Anaemia - low red blood cells worsen fatigue; transfusions may be needed
- Peripheral neuropathy - tingling or numbness in hands and feet; more common with cisplatin and paclitaxel; can persist after treatment ends
- Kidney toxicity - cisplatin requires IV hydration; regular kidney function tests are essential
Before starting, ask your oncologist about anti-nausea medicines (prescribed proactively), whether a PICC line suits you, and how to plan for low-energy days post-infusion. Disclose all supplements - many interact with chemotherapy drugs.
Conclusion
Chemotherapy can sound intimidating at first, but many people go through treatment with side effects that can be managed well with today’s supportive care. Your oncology team will choose the medicines and treatment schedule based on your type of lung cancer and your overall health. They’ll also help manage symptoms and keep you as comfortable as possible during treatment. Knowing what the process looks like ahead of time can make the experience feel less uncertain and easier to handle.
